Biotech

All Articles

BioMarin standstills preclinical gene therapy for heart condition

.After BioMarin carried out a springtime well-maintained of its pipeline in April, the firm has deci...

Eisai plants molecular glue SEED along with $1.5 B biobucks handle

.Huge Pharmas continue to be caught to the concept of molecular adhesive degraders. The latest firm ...

Life scientific research credit history company reveals along with $600M

.A brand new international life scientific research credit report firm, dubbed Symbiotic Resources, ...

BMS channels TIGIT, bowing out $200M bank on Agenus bispecific

.Bristol Myers Squibb is axing yet another major wager from the Caforio period, canceling a deal for...

Nuvation standstills wager prevention after taking into consideration stage 1 record

.After taking a look at phase 1 record, Nuvation Biography has decided to halt work with its one-tim...

' Scientific instinct' led FDA experts to support Zevra's rare ailment med

.Zevra Therapeutics' unusual disease medication appears to become on the path to authorization this ...

Pfizer takes $230M struck after axing failed DMD gene therapy

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) gene treatment failing has actually blown a $230 ...

AC Immune sees 'site' potential in Alzheimer's medicine data

.After greater than twenty years of deal with neurodegenerative diseases, Swiss biotech a/c Immune s...

GSK drops ph. 2 HPV injection over absence of best-in-class possible

.GSK has actually ditched a stage 2 individual papillomavirus (HPV) vaccination coming from its own ...

OS Treatments refiles $6M IPO to fund HER2 medicine, preclinical ADCs

.Operating system Therapies will list on the NYSE American supply swap today via a $6.4 million IPO ...